The prognostic significance of immune microenvironment in breast ductal carcinoma in situ
Michael S. Toss(Nottingham City Hospital), Emad A. Rakha(Nottingham University Hospitals NHS Trust)
Cited by 44
Related Papers
Artificial intelligence in digital breast pathology: Techniques and applications
|The Breast|2019|200
Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer
|Breast Cancer Research|2012|126
MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours
|British Journal of Cancer|2016|125
Biological and clinical significance of PARP1 protein expression in breast cancer
|Breast Cancer Research and Treatment|2014|83